Vai al contenuto principale della pagina

Cellular and Molecular Mechanisms in Pathogenesis of Multiple Sclerosis



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Wan Edwin Visualizza persona
Titolo: Cellular and Molecular Mechanisms in Pathogenesis of Multiple Sclerosis Visualizza cluster
Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica: 1 electronic resource (182 p.)
Soggetto topico: Medicine
Soggetto non controllato: neutrophils
lymphocytes
NLR
multiple sclerosis
disease activity
inside-out
outside-in
oligodendrocytosis
demyelination
gliosis
histology
top-down proteomics
bioinformatics
mitochondria
CD4+ T cells
memory T cells
autoimmune disease
effector memory T cell
central memory T cell
tissue-resident T cell
experimental autoimmune encephalomyelitis
monocytes
granulocyte-macrophage colony-stimulating factor
S100B
relapsing-remitting experimental autoimmune encephalomyelitis
pentamidine
NG2-glia
progenitors
lineage
in utero electroporation
morphometric analyses
clonal analyses
lesioned brain
sphingosine-1-phosphate receptors
glutamate synaptic dysfunction
microglia
T lymphocytes
experimental autoimmune encephalomyelitis (EAE)
pro-inflammatory cytokines
neuroinflammation
ozanimod
AUY954
A971432
S1P1
S1P5
kynurenine pathway
kynurenic acid
oxidative stress
quinolinic acid
N-acetylserotonin
IDO
NAD+, multiple sclerosis
laquinimod
Persona (resp. second.): WanEdwin
Sommario/riassunto: Multiple sclerosis (MS) is one of the most common neurological disorders in young adults. The etiology of MS is not known, but it is generally accepted that it is autoimmune in nature. Our knowledge of the pathogenesis of MS has increased tremendously in the past decade through clinical studies and the use of experimental autoimmune encephalomyelitis (EAE), a model that has been widely used for MS research. Major advances in the field, such as understanding the roles of pathogenic Th17 cells, myeloid cells, and B cells in MS/EAE, as well as cytokine and chemokine signaling that controls neuroinflammation, have led to the development of potential and clinically approved disease-modifying agents (DMAs). There are many aspects related to the initiation, relapse and remission, and progression of MS that are yet to be elucidated. For instance, what are the genetic and environmental risk factors that promote the initiation of MS, and how do these factors impact the immune system? What factors drive the progression of MS, and what are the roles of peripheral immune cells in disease progression? How do the CNS-infiltrated immune cells interact with the CNS-resident glial cells when the disease progresses? What is the role of microbiome in MS? Can we develop animal models that better represent subcategories of MS? Understanding the cellular and molecular mechanisms that govern the pathogenesis of MS will help to develop novel and more specific therapeutic strategies that will ultimately improve clinical outcomes of the treatments. This Special Issue of Cells has published original research articles, a retrospective clinical report, and review articles that investigate the cellular and molecular basis of MS.
Titolo autorizzato: Cellular and Molecular Mechanisms in Pathogenesis of Multiple Sclerosis  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910557306103321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui